[{"NetIncomeLoss_1_Q2_USD":-83000000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":587000000.0,"Depreciation_2_Q2_USD":163000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-280000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-715000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2499000000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2_Q2_USD":-122000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":9000000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q2_USD":-133000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":437000000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.575,"CommonStockDividendsPerShareDeclared_2_Q2_USD":1.15,"CommercialPaper_0_Q2_USD":0.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-130000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":0.0,"RepaymentsOfLongTermDebt_2_Q2_USD":500000000.0,"AssetsCurrent_0_Q2_USD":12801000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":2555000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":1225000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":26000000.0,"LineOfCreditFacilityRemainingBorrowingCapacity_0_Q2_USD":2904000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.1,"AccruedIncomeTaxesNoncurrent_0_Q2_USD":990000000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":1570000000.0,"ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_2_Q2_USD":-68000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":406000000.0,"ShareBasedCompensation_2_Q2_USD":86000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-92000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-109000000.0,"Assets_0_Q2_USD":31483000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":158000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4300000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":2293000000.0,"ContractWithCustomerLiability_0_Q2_USD":379000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":0.0,"ProductLiabilityAccrualPeriodExpense_2_Q2_USD":-6000000.0,"Liabilities_0_Q2_USD":18729000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":320000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":93000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2203000000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-375000000.0,"AssetsFairValueDisclosure_0_Q2_USD":6873000000.0,"PrepaidExpenseCurrent_0_Q2_USD":537000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":375500000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-4000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":379900000.0,"AdjustmentForAmortization_2_Q2_USD":228000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":442000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.22,"EarningsPerShareBasic_2_Q2_USD":1.09,"OtherLongTermDebt_0_Q2_USD":25000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":233000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-17000000.0,"Revenues_2_Q2_USD":6352000000.0,"Revenues_1_Q2_USD":2764000000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsTax_2_Q2_USD":23000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":6539000000.0,"OtherAssetsNoncurrent_0_Q2_USD":1499000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":110000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":228000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-175000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":301000000.0,"MachineryAndEquipmentGross_0_Q2_USD":3330000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":181000000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":31000000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":80000000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":74000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1288000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_Rate":0.046,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_Rate":0.185,"OtherComprehensiveIncomeLossBeforeReclassificationsTax_1_Q2_USD":49000000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1706000000.0,"ProductLiabilityAccrualPeriodExpense_1_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-34000000.0,"CommonStockValueOutstanding_0_Q2_USD":38000000.0,"CostOfRevenue_2_Q2_USD":2473000000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":41000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":375500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":375100000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1211000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-58000000.0,"CostOfRevenue_1_Q2_USD":1216000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-45000000.0,"Goodwill_0_Q2_USD":9074000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2248000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":419000000.0,"MarketableSecuritiesGainLoss_1_Q2_USD":25000000.0,"MarketableSecuritiesGainLoss_2_Q2_USD":65000000.0,"DebtInstrumentFairValue_0_Q2_USD":13984000000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q2_USD":785000000.0,"LiabilitiesCurrent_0_Q2_USD":4405000000.0,"NonoperatingIncomeExpense_2_Q2_USD":-112000000.0,"NonoperatingIncomeExpense_1_Q2_USD":-67000000.0,"NetIncomeLoss_2_Q2_USD":410000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2527000000.0,"PaymentsOfDividends_2_Q2_USD":431000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-14000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":12754000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":4800000.0,"ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_2_Q2_USD":8000000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0303,"GrossProfit_1_Q2_USD":1548000000.0,"GrossProfit_2_Q2_USD":3879000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":4012000000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":214000000.0,"LongTermDebtNoncurrent_0_Q2_USD":11811000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":6539000000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":23000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":388000000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.22,"EarningsPerShareDiluted_2_Q2_USD":1.08,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":528000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":31483000000.0,"OperatingLeaseCost_1_Q2_USD":31000000.0,"OperatingLeaseCost_2_Q2_USD":67000000.0,"BusinessCombinationConsiderationTransferred1_2_Q2_USD":26000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":4000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":8000000.0,"InventoryNet_0_Q2_USD":3442000000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-39000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"AccountsPayableTradeCurrent_0_Q2_USD":635000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-87000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":503000000.0,"OperatingIncomeLoss_1_Q2_USD":-20000000.0,"OperatingIncomeLoss_2_Q2_USD":615000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4775000000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":487000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":92000000.0,"OperatingExpenses_2_Q2_USD":3264000000.0,"AssetImpairmentCharges_1_Q2_USD":189000000.0,"AssetImpairmentCharges_2_Q2_USD":161000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-671000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":2202000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":11725000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q2_USD":-30000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2_Q2_USD":-56000000.0,"DebtCurrent_0_Q2_USD":1110000000.0,"DebtLongtermAndShorttermCombinedAmount_0_Q2_USD":12921000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":114000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":253000000.0,"DividendsPayableCurrent_0_Q2_USD":216000000.0,"OtherLiabilitiesCurrent_0_Q2_USD":1702000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1523000000.0,"OperatingExpenses_1_Q2_USD":1568000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":230000000.0,"EntityCommonStockSharesOutstanding_0_Q2_shares":375605813.0,"Ticker":"SYK","CIK":"310764","name":"STRYKER CORP","OfficialName":"Stryker Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"102609776659.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"SP500","filed":"20200731"}]